Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ellis Martini

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Best Practice & Research. Clinical Endocrinology & Metabolism|October 29, 2021
The role of hormone therapy in urogenital health after menopauseRossella E Nappi, Laura Cucinella, Ellis Martini, et al.
Expert Opinion on Pharmacotherapy|March 1, 2018
Has flibanserin revolutionized the treatment of hypoactive sexual desire disorder or is there still room for more effective therapeutics?Rossella E Nappi, Laura Cucinella, Lara Tiranini, et al.
The Urologic Clinics of North America|April 16, 2022
Medical Treatment of Female Sexual DysfunctionRossella E Nappi, Lara Tiranini, Ellis Martini, et al.
Expert Review of Clinical Pharmacology|April 20, 2025
A profile of safety and efficacy of fezolinetant for the treatment of menopausal vasomotor symptomsLaura Cucinella, Chiara Cassani, Sara Tedeschi, et al.
Climacteric : the Journal of the International Menopause Society|April 22, 2025
Bringing sex back into the relationship in midlife couplesRossella E Nappi, Lara Tiranini, Ellis Martini, et al.
Maturitas|November 9, 2016
Female sexual dysfunction (FSD): Prevalence and impact on quality of life (QoL)Rossella E Nappi, Laura Cucinella, Silvia Martella, et al.
Healthcare (Basel, Switzerland)|August 26, 2022
Hyaluronic Acid: A Valid Therapeutic Option for Early Management of Genitourinary Syndrome of Menopause in Cancer Survivors?Rossella E Nappi, Silvia Martella, Francesca Albani, et al.
Expert Review of Neurotherapeutics|April 11, 2023
Is now the time to reconsider risks, benefits, and limitations of estrogen preparations as a treatment for menstrually related migraine?Lara Tiranini, Laura Cucinella, Silvia Martella, et al.
Expert Opinion on Drug Metabolism & Toxicology|October 11, 2024
Pharmacokinetic evaluation of fezolinetant for the treatment of vasomotor symptoms caused by menopauseLaura Cucinella, Sara Tedeschi, Stefano Memoli, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|April 12, 2014
Counseling and management of patients requesting subcutaneous contraceptive implants: proposal for a decisional algorithmMaurizio Guida, Federica Visconti, Francesca Cibarelli, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Best Practice & Research. Clinical Endocrinology & Metabolism|October 29, 2021
The role of hormone therapy in urogenital health after menopauseRossella E Nappi, Laura Cucinella, Ellis Martini, et al.
Expert Opinion on Pharmacotherapy|March 1, 2018
Has flibanserin revolutionized the treatment of hypoactive sexual desire disorder or is there still room for more effective therapeutics?Rossella E Nappi, Laura Cucinella, Lara Tiranini, et al.
The Urologic Clinics of North America|April 16, 2022
Medical Treatment of Female Sexual DysfunctionRossella E Nappi, Lara Tiranini, Ellis Martini, et al.
Expert Review of Clinical Pharmacology|April 20, 2025
A profile of safety and efficacy of fezolinetant for the treatment of menopausal vasomotor symptomsLaura Cucinella, Chiara Cassani, Sara Tedeschi, et al.
Climacteric : the Journal of the International Menopause Society|April 22, 2025
Bringing sex back into the relationship in midlife couplesRossella E Nappi, Lara Tiranini, Ellis Martini, et al.
Maturitas|November 9, 2016
Female sexual dysfunction (FSD): Prevalence and impact on quality of life (QoL)Rossella E Nappi, Laura Cucinella, Silvia Martella, et al.
Healthcare (Basel, Switzerland)|August 26, 2022
Hyaluronic Acid: A Valid Therapeutic Option for Early Management of Genitourinary Syndrome of Menopause in Cancer Survivors?Rossella E Nappi, Silvia Martella, Francesca Albani, et al.
Expert Review of Neurotherapeutics|April 11, 2023
Is now the time to reconsider risks, benefits, and limitations of estrogen preparations as a treatment for menstrually related migraine?Lara Tiranini, Laura Cucinella, Silvia Martella, et al.
Expert Opinion on Drug Metabolism & Toxicology|October 11, 2024
Pharmacokinetic evaluation of fezolinetant for the treatment of vasomotor symptoms caused by menopauseLaura Cucinella, Sara Tedeschi, Stefano Memoli, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|April 12, 2014
Counseling and management of patients requesting subcutaneous contraceptive implants: proposal for a decisional algorithmMaurizio Guida, Federica Visconti, Francesca Cibarelli, et al.
Pageof 3